内囊前肢腹侧脑深部电刺激治疗难治性强迫症的长期结局:50例队列研究
该研究纳入50例严重难治性强迫症患者,接受内囊前肢腹侧脑深部电刺激(DBS)并随访至少3年(平均6.8±3年)。长期随访显示强迫症状减少39%,半数患者为应答者,焦虑和抑郁症状分别减少48%和50%,生活质量和功能显著改善, unemployment率从78%降至58%(p=.058),21例患者停用或减少精神药物(p=.004)。长期不良事件包括认知抱怨和疲劳,严重不良事件包括1例与共病抑郁相关的自杀未遂。
要点
- 内囊前肢腹侧DBS可使难治性强迫症强迫症状长期减少39%,半数患者应答。
- 焦虑和抑郁症状分别减少48%和50%,生活质量和功能显著改善。
- 长期不良事件包括认知抱怨和疲劳,需关注共病抑郁相关的自杀风险。
核心结论
- 内囊前肢腹侧DBS对难治性强迫症具有长期有效性和耐受性,并改善功能与整体幸福感。
研究设计与样本
- 50例严重难治性强迫症患者接受内囊前肢腹侧DBS,植入后随访至少3年(平均6.8±3年)。
- 主要有效性指标为耶鲁-布朗强迫量表评分变化,次要指标包括汉密尔顿焦虑量表、汉密尔顿抑郁量表、世界卫生组织生活质量简表、全球功能评估及工作家庭社交功能量表。
- 采用结构化访谈(n=38)评估DBS不良事件。
主要发现
- 长期随访时强迫症状减少39%(p<.001),半数患者为应答者(耶鲁-布朗强迫量表评分减少≥35%)。
- 焦虑和抑郁症状分别减少48%和50%,世界卫生组织生活质量简表总体评分及4个子域中的3个显著改善。
- 临床医生和患者评定的功能均显著改善(p<.001)。
- 失业率从基线78%降至末次随访58%(z=-1.90,p=.058),21例患者停用或减少精神药物(z=-2.887,p=.004)。
- 长期不良事件包括认知抱怨和疲劳,严重不良事件包括1例与共病抑郁相关的自杀未遂。
关键数值与推荐
- 强迫症状减少39%(p<.001),应答定义为耶鲁-布朗强迫量表评分减少≥35%,半数患者达到应答。
- 焦虑症状减少48%,抑郁症状减少50%。
- 失业率从78%降至58%(z=-1.90,p=.058),21例患者停用或减少精神药物(z=-2.887,p=.004)。
临床怎么用
- 对于严重难治性强迫症,内囊前肢腹侧DBS可作为长期治疗选择,需评估认知抱怨和疲劳等不良事件。
- 治疗中应监测共病抑郁及自杀风险,并关注功能和生活质量的改善。
局限性
- 不良事件评估仅基于38例的结构化访谈,样本量有限。
- 失业率变化未达到统计学显著性(p=.058)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep brain stimulation (DBS) is an effective intervention for patients with severe treatment-refractory obsessive-compulsive disorder (OCD). Our aim was to examine long-term effectiveness and tolerability of DBS and its impact on functioning and well-being. METHODS: Fifty patients with severe treatment-refractory OCD received DBS of the ventral part of the anterior limb of the internal capsule and were followed for at least 3 years following implantation (mean 6.8 ± 3 years). Primary effectiveness was assessed by change in Yale-Brown Obsessive Compulsive Scale scores. Secondary effectiveness measures included Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, World Health Organization Quality of Life Scale-Brief Version, Global Assessment of Functioning, and a scale assessing functioning in work, family, and social life. Adverse effects of DBS were examined with a structured interview (n = 38). RESULTS: At long-term follow-up, OCD symptoms decreased by 39% (p < .001), and half of the patients were responders (≥35% decrease of Yale-Brown Obsessive Compulsive Scale score). Anxiety and depressive symptoms decreased significantly, with reductions of 48% and 50%, respectively. The World Health Organization Quality of Life Scale-Brief Version general score improved significantly, as did 3 of 4 subdomains. Both clinician- and patient-rated functioning improved substantially (p < .001). The unemployment rate decreased from 78% at baseline to 58% at last follow-up (z = -1.90, p = .058), and 21 patients stopped or decreased psychotropic medication (z = -2.887, p = .004). Long-term adverse effects included cognitive complaints and fatigue. Serious adverse events included 1 suicide attempt, related to comorbid depression. CONCLUSIONS: Our results provide evidence that DBS of the ventral part of the anterior limb of the internal capsule is effective and tolerable for treatment-refractory OCD in the long term and improves functioning and overall well-being.
引用
- Graat I, Mocking R, Figee M, et al. Long-term Outcome of Deep Brain Stimulation of the Ventral Part of the Anterior Limb of the Internal Capsule in a Cohort of 50 Patients With Treatment-Refractory Obsessive-Compulsive Disorder. Biol Psychiatry. 2020. PMID: 33131717. doi:10.1016/j.biopsych.2020.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。